ColoPlus products are formulated to slow down and control the time required to empty the stomach, thus prolonging the transit time of bioactive compounds through the digestive tract. This increases the contact time of the bioactivities with the mucosal surface of the gastrointestinal tract and strengthens the local immunological response. The survival and resistance of the bioactive components in the GI tract are also enhanced.
Bioactive immunoglobulins from colostrum are not absorbed by the body when administered orally but remain in the digestive tract, where they exert a local effect. There, they attack food- and water-borne organisms that cause disease. ColoPlus® IMCARE is effective in preventing intestinal infections by first preventing bacteria from attaching to the intestinal wall and then destroying them. A systemic effect is achieved through the presence of growth factors, bioactive peptides, and micronutrients. No side effects have been reported.
Prolonged effect. During studies, a prolonged effect of ColoPlus IMCARE was observed for at least four weeks, as CD4+ counts increased. This prolonged effect makes ColoPlus IMCARE cost-efficient.
